Cancer Hospital, Chinese Academy of Medical Sciences
Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, China20 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| a PROspective Case Control Study to Develop and Validate a Blood Test FOr mUlti-caNcers Early Detection(PROFOUND) | cancer, neoplasm | Recruiting | Not stated | 2026-09-11 | NCT06217900 | |
| Phase I Study of SM2275 Injection in Patients With Advanced Solid Tumors | Advanced Solid Tumors | Not yet recruiting | Phase 1 | 2026-09-08 | NCT07750132 | |
| PTT-936 Alone or in Combination in Patients With Locally Advanced or Metastatic Solid Tumors | Locally Advanced or Metastatic Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2026-08-10 | NCT06244992 | |
| Radiotherapy After Prostatectomy for Node Positive Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 3 | 2026-06-16 | NCT07477626 | |
| Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer | HER2-Negative Locally Advanced Breast Cancer | Recruiting | Phase 2 | 2026-06-10 | NCT06908668 | |
| Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid cell neoplasm, hematopoietic and lymphoid system neoplasm, neoplasm | Recruiting | Phase 2 | 2026-05-07 | NCT07043894 | |
| Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors | Adolescent; Chemotherapy Induced Neutropenia; Children; Solid Tumors | Recruiting | Phase 2 | 2026-05-07 | NCT06926751 | |
| A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in the Treatment of Relapsed and Refractory Solid Tumors in Children, Adolescents and Young Adults | Adolescents; Children; Solid Tumors | Recruiting | Phase 2 | 2026-05-07 | NCT06761417 | |
| Golidocitinib With PD-1 Inhibitors as Maintenance Treatment for Previously Untreated ES-SCLC | SCLC; SCLC, Extensive Stage | Recruiting | Phase 2 | 2026-02-27 | NCT07110103 | |
| Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations | Cirrhosis, Familial, with Pulmonary Hypertension, Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, neoplasm | Not yet recruiting | Phase 3 | 2026-01-09 | NCT07328919 | |
| HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Recruiting | Phase 3 | 2025-12-17 | NCT06855069 | |
| JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2025-09-12 | NCT06079983 | |
| A Study of ES014 in Subjects With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 2 | 2025-07-30 | NCT06543056 | |
| Intracorporeal Anastomosis Versus Extracorporeal Anastomosis for Left Colon Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, malignant colon neoplasm, neoplasm | Active, not recruiting | Not applicable | 2025-05-07 | NCT04201717 | |
| Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCC | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, neoplasm, squamous cell carcinoma, squamous cell neoplasm | Not yet recruiting | Phase 2 / Phase 3 | 2025-03-11 | NCT06861777 | |
| A Study Comparing the Differences Between Young and Non-young Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Enrolling by invitation | Not stated | 2025-02-14 | NCT06793306 | |
| Safety and Efficacy of Intravenous IDOV-SAFETM in Patients With Advanced Solid Tumors | neoplasm | Recruiting | Early phase 1 | 2025-02-04 | NCT06346041 | |
| A Study of MT027 in Patients with Pleural Malignant Tumors | Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pleural Effusion, Pleural Effusion, Malignant, Thoracic Neoplasms, adenoma, epithelial neoplasm, lung disorder, lung neoplasm, malignant mesothelioma, malignant pleural mesothelioma, mesothelial neoplasm, mesothelioma, neoplasm, pleural disorder, pleural mesothelioma, pleural neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 | 2024-12-10 | NCT06726564 | |
| A Study of BA1202 in Patients With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 | 2024-04-25 | NCT05909241 | |
| Study of LY01610 in Patients With Recurrent Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Phase 3 | 2024-03-15 | NCT06128837 |